ArticleJournal of the National Cancer Institute2026

Pembrolizumab with or without chemotherapy among older adults with advanced lung adenocarcinoma: a national, nonrandomized open-label phase II trial (Alliance A171901).

Melisa L Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.